← Back
Sanofi
SNY · listed on Nasdaq · worth $107.57 billion
$43.13
+2.11% on Oct 29
No insider trades reported for Sanofi yet. One member of Congress reported trading Sanofi in the last year.
No insider trades or company news in this range.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
2.2B shares
90% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Big investors
People and funds that reported owning 5% or more of Sanofi, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateAmundi5.7%Oct 26
US Congress
Members of Congress who reported trading Sanofi in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Sanofi.
Newest first
No insider trades reported for SNY yet.
Analysts, earnings and news
Analysts' price target
$53.61 average
9 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q2 '26$1.20 a share+$0.06
Q1 '26$1.10 a share+$0.07
Q4 '25$0.91 a share+$0.06
Q3 '25$1.69 a share+$0.13